UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000031120
Receipt No. R000035542
Scientific Title Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor
Date of disclosure of the study information 2018/02/02
Last modified on 2021/03/22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor
Acronym Retrospective Study of thoracic tumor
Scientific Title Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor
Scientific Title:Acronym Retrospective Study of thoracic tumor
Region
Japan

Condition
Condition Chest tumor which is represented by lung cancer, thymus epithelium tumor, and malignant pleural mesothelioma
Classification by specialty
Pneumology Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Using existing administrative data, we analize the clinicopathologic characteristic, an effect, safety of the treatment.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes To explore factors related with curative effect, convalescence, complications.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patient who the diagnosis of chest tumor, an operation, chemotherapy, radiotherapy, relaxation care were carried out in the Jikei-Daisan Hospital until December 31, 2017.
Key exclusion criteria The patients who refused to participate in our study.
Target sample size 300

Research contact person
Name of lead principal investigator
1st name Naoki
Middle name
Last name Takasaka
Organization The Jikei Daisan Hospital, Japan
Division name Division of Respirology, Department of Internal Medicine
Zip code 201-8601
Address 4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan
TEL 03-3480-1151
Email ntakasak@gmail.com

Public contact
Name of contact person
1st name Naoki
Middle name
Last name Takasaka
Organization The Jikei Daisan Hospital, Japan
Division name Division of Respirology, Department of Internal Medicine
Zip code 201-8601
Address 4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan
TEL 03-3480-1151
Homepage URL
Email ms97-seki@jikei.ac.jp

Sponsor
Institute The Jikei Daisan Hospital, Japan
Institute
Department

Funding Source
Organization The Jikei Daisan Hospital, Japan
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The Jikei Daisan Hospital, Japan
Address 4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan
Tel 03-3480-1151
Email rinri@jikei.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京慈恵会医科大学附属第三病院(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 02 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 02 Month 23 Day
Date of IRB
2018 Year 05 Month 15 Day
Anticipated trial start date
2018 Year 12 Month 31 Day
Last follow-up date
2020 Year 12 Month 31 Day
Date of closure to data entry
2020 Year 12 Month 31 Day
Date trial data considered complete
2020 Year 12 Month 31 Day
Date analysis concluded
2021 Year 12 Month 31 Day

Other
Other related information Retrospective analysis

Management information
Registered date
2018 Year 02 Month 02 Day
Last modified on
2021 Year 03 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035542

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.